Skip to Content

Lescol Side Effects

Generic Name: fluvastatin

Note: This document contains side effect information about fluvastatin. Some of the dosage forms listed on this page may not apply to the brand name Lescol.

In Summary

More frequent side effects include: dyspepsia, myalgia, and accidental injury. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to fluvastatin: oral capsule, oral tablet extended release

Along with its needed effects, fluvastatin (the active ingredient contained in Lescol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking fluvastatin:

More common Less common
  • Bladder pain
  • bloody or cloudy urine
  • cough producing mucus
  • dark-colored urine
  • difficult, burning, or painful urination
  • difficulty with breathing
  • difficulty with moving
  • difficulty with swallowing
  • dizziness
  • fast heartbeat
  • frequent urge to urinate
  • hives
  • itching
  • lower back or side pain
  • muscle cramps, spasms, or stiffness
  • muscular pain, tenderness, wasting, or weakness
  • pain, swelling, or redness in the joints
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • skin rash
  • tightness in the chest

Some side effects of fluvastatin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common Less common
  • Bloated or full feeling
  • excess air or gas in the stomach or intestines
  • pain or tenderness around the eyes and cheekbones
  • passing gas
  • unable to sleep

For Healthcare Professionals

Applies to fluvastatin: oral capsule, oral tablet extended release


The most frequently reported side effects were headache, dyspepsia, abdominal pain, nausea, and myalgia.[Ref]


Common (1% to 10%): Myalgia, arthritis, arthropathy, arthralgia, pain in extremity, back pain
Rare (0.01% to 0.1%): Muscular weakness, myopathy
Very rare (less than 0.01%): Rhabdomyolysis, myositis, lupus erythematosus-like syndrome
Frequency not reported: Immune-mediated necrotizing myopathy
Postmarketing reports: Muscle cramps, muscle spasms[Ref]


Common (1% to 10%): ALT increased, AST increased
Very rare (less than 0.01%): Hepatitis
Postmarketing reports: Chronic active hepatitis, cholestatic jaundice, fatty change in liver, cirrhosis, fulminant hepatic necrosis, fatal hepatic failure, nonfatal hepatic failure, gamma-glutamyl transpeptidase increased, bilirubin increased[Ref]


Common (1% to 10%): Dyspepsia, diarrhea, abdominal pain, nausea, flatulence, tooth disorder, upper abdominal pain, constipation, gastric disorder
Very rare (less than 0.01%): Pancreatitis
Postmarketing reports: Vomiting[Ref]


Common (1% to 10%): Rash
Rare (0.01% to 0.1%): Urticaria
Very rare (less than 0.01%): Angioedema, face edema, eczema, dermatitis, bullous exanthema
Postmarketing reports: Bullous dermatitis, alopecia, pruritus, skin nodules, skin discoloration, dry skin/mucous membranes, hair/nails changed[Ref]


Very common (10% or more): Upper respiratory tract infection (16.2%)
Common (1% to 10%): Sinusitis, bronchitis, nasopharyngitis, exertional dyspnea, pharyngitis, rhinitis, cough[Ref]


Common (1% to 10%): Influenza-like symptoms, accidental trauma, fatigue, peripheral edema, blood transaminases increased, creatine phosphokinase increased
Uncommon (0.1% to 1%): Chest pain
Postmarketing reports: Vertigo, alkaline phosphatase increased[Ref]

Nervous system

Common (1% to 10%): Headache, dizziness, syncope
Very rare (less than 0.01%): Paresthesia, dysesthesia, hypoesthesia
Postmarketing reports: Tremor, peripheral nerve palsy, peripheral neuropathy, dysfunction of cranial nerve, alteration of taste, extra-ocular movement impaired, facial paresis, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment[Ref]


Common (1% to 10%): Urinary tract infection
Postmarketing reports: Erectile dysfunction, gynecomastia[Ref]


Common (1% to 10%): Atrial fibrillation, hypertension, intermittent claudication
Very rare (less than 0.01%): Vasculitis[Ref]


Very rare (less than 0.01%): Thrombocytopenia[Ref]


Frequency not reported: Myoglobinuria, acute renal failure[Ref]


Common (1% to 10%): Allergy
Very rare (less than 0.01%): Anaphylactic reaction[Ref]


An apparent hypersensitivity syndrome was reported rarely and included one or more of the following: anaphylaxis, angioedema, lupus erythematosus-like syndrome, polymyalgia rheumatica, vasculitis, purpura, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibodies, erythrocyte sedimentation rate increased, eosinophilia, arthritis, arthralgia, urticaria, asthenia, photosensitivity reaction, fever, chills, flushing, malaise, dyspnea, toxic epidermal necrolysis, erythema multiforme, and Stevens-Johnson syndrome.[Ref]

Rare (less than 0.1%): Hypersensitivity reaction[Ref]


Postmarketing reports: Hepatoma[Ref]


Postmarketing reports: Thyroid function abnormal[Ref]


Common (1% to 10%): Insomnia
Postmarketing reports: Anxiety, depression, psychic disturbances, loss of libido, confusion[Ref]


Frequency not reported: HbA1c increased, serum glucose increased
Postmarketing reports: Anorexia[Ref]


Postmarketing reports: Cataracts progressed, lens opacity, ophthalmoplegia[Ref]


1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Lescol (fluvastatin)." Novartis Pharmaceuticals, East Hanover, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.